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Frog oocyteHere we set out to evaluate the role of hexokinase and glycogen synthase in the control of glycogen
synthesis in vivo. We used metabolic control analysis (MCA) to determine the ﬂux control coefﬁcient
for each of the enzymes involved in the pathway. Acute microinjection experiments in frog oocytes
were speciﬁcally designed to change the endogenous activities of the enzymes, either by directly
injecting increasing amounts of a given enzyme (HK, PGM and UGPase) or by microinjection of a
positive allosteric effector (glc-6P for GS). Values of 0.61 ± 0.07, 0.19 ± 0.03, 0.13 ± 0.03, and
0.06 ± 0.08 were obtained for the ﬂux control coefﬁcients of hexokinase EC 2.7.1.1 (HK), phospho-
glucomutase EC 5.4.2.1 (PGM), UDPglucose pyrophosphorylase EC 2.7.7.9 (UGPase) and glycogen syn-
thase EC 2.4.1.11 (GS), respectively. These values satisfy the summation theorem since the sum of the
control coefﬁcients for all the enzymes of the pathway is 0.87. The results show that, in frog oocytes,
glycogen synthesis through the direct pathway is under the control of hexokinase. Phosphogluco-
mutase and UDPG-pyrophosphorylase have a modest inﬂuence, while the control exerted by glyco-
gen synthase is null.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Almost 60 years elapsed since Michaelis and Menten published
their results in enzyme kinetics for isolated enzymes in 1913 [1]
and the appearance of Metabolic Control Analysis (MCA), devel-
oped in the early 1970s by Kacser and Burns [2] and Heinrich
and Rapoport [3]. Despite increased interest to study ﬂux control
through metabolic pathways by means of MCA, the concept of
rate-limiting enzymes is nevertheless widely accepted. This is the
case for glycogen synthase, still viewed by many as the enzyme
controlling the ﬂux in glycogen formation, mainly because the
enzyme is subjected to several regulatory mechanisms, such as
sensitivity to allosteric effectors [4], covalent phosphorylation
[5], modiﬁcation by nucleo-cytoplasmic relocation [6], and speciﬁc
proteolysis mediated by maline and laforine [7]. This rate-limiting
concept for GS has been challenged by authors who have appliedthe MCA approach to the study of ﬂux control in the pathway. In
vivo studies performed by different groups suggest that the control
of the ﬂux is at the level of the glucose transporter and hexokinase
[8,9] or is exerted by hexokinase [10]. Also, it has been shown that
glucokinase exerts a high control of the ﬂux in hepatocytes, which
is dependent on compartmentation of the enzyme [11]. The major
determinant of the high control coefﬁcient of glucokinase would be
the negative control coefﬁcient of the glucokinase regulatory
protein [12].
As pointed out by MCA, several enzymes might affect the ﬂux in
a pathway, sharing its control. Quantifying the response of the ﬂux
to a change in enzyme activity requires measurement of the ﬂux
and of enzyme activity. The magnitude of the effect is expressed
in terms of the ﬂux control coefﬁcient for a given enzyme, and is
deﬁned as the ratio between the fractional changes in the enzyme
and the ﬂux [13]. Mathematically, it implies that the ﬂux control
coefﬁcient may be obtained from the slope of the tangent on a plot
of the logarithm of the ﬂux versus the logarithm of enzyme activ-
ity. According to the summation theorem, the addition of the ﬂux
control coefﬁcients for all the enzymes involved in the pathway
is 1.0. If all the enzymes of the pathway affect the ﬂux, then their
ﬂux control coefﬁcients should be very low. A corollary of this
statement is that if the ﬂux control coefﬁcient of an enzyme is
1.0, the other enzymes of the pathway will have ﬂux control
2826 A. Preller et al. / FEBS Letters 587 (2013) 2825–2831coefﬁcients equal to 0; only in this case this particular enzymemay
be considered as the rate-limiting enzyme.
Metabolic ﬂux measurements under in vivo conditions are
relatively scarce because of experimental limitations. Control coef-
ﬁcients have been usually estimated by supplementing tissue
homogenates with puriﬁed enzymes. This system has several
disadvantages, such as dilution of homogenates compared to the
intracellular medium and loss of cellular organization. The possi-
bility then is to change the activity of a particular enzyme by over-
expression, or by the use of knock out organisms or enzyme
activity modiﬁers. Nevertheless, even when only a single gene
has been introduced to a cell the expression of other proteins
may show altered levels [14]. In early work, we have shown that
amphibian oocytes are a powerful tool for metabolic studies
in vivo. The advantages of this system have been described
elsewhere for a review see [15]. Concerning the present research,
measurement of the ﬂux through the glycogen synthesis pathway
and intracellular variation of the enzyme activities involved were
easily performed in oocytes.
After radioactive glucose microinjection into Caudiverbera
caudiverbera oocytes, around 95% of the label is incorporated into
glycogen. The synthesis proceeds both by the classic direct and
the indirect pathways. The latter implies glycolytic degradation
of glucose to pyruvate or lactate followed by gluconeogenic syn-
thesis of glucose-6-P with further metabolization to glycogen
[16]. The preferential operation of one pathway over the other
depends on glucose availability [17].
Our aim in this work was to determine the ﬂux control coefﬁ-
cients in vivo for all the enzymes involved in glycogen synthesis
through the direct pathway, and to elucidate if the ﬂux was under
the control of hexokinase or glycogen synthase. We concluded that,
in frog oocytes, glycogen synthesis through the direct pathway is
under the control of hexokinase. Phosphoglucomutase and
UDPG-pyrophosphorylase have a modest inﬂuence, while the
control exerted by glycogen synthase is null.
2. Materials and methods
2.1. Materials
HK (H 5625), UGPase (U 8501), Glc-6-P dehydrogenase (G
8404), and metabolites were from Sigma Chemical Co. UDP-
[6-3H]-glucose and U-14C-glucose were obtained from Amersham.
PGM (9001-81-4) was from Roche. Other reagents were mostly
from Merck and Sigma–Aldrich, IL, USA.
2.2. Animals and cells
Female frogs C. caudiverbera were obtained from a local dealer,
kept in tap water and fed once a week with chicken or bovine liver.
An ovary fragment was removed from cold anaesthetized frogs by
a small costal incision and placed in a beaker containing amphibian
modiﬁed Barth saline [18]. Individual, same size stage VI oocytes
[19] were manually released from surrounding tissue by blunt dis-
section with jeweler’s forceps and kept in saline until used. Animal
use and experimental procedures were approved by the Faculty of
Sciences local Ethics Committee, in accordance with Conicyt (Com-
isión Nacional de Investigación Cientíﬁca y Tecnológica).
2.3. Substrate microinjection
Oocytes were microinjected with calibrated glass needles in the
equatorial zone under a Nikon 102 magnifying glass using a
Narishige IM-200 automatic injector. Volume injection was around
50 nl. Before injection, radioactive substrates were dried by
evaporation in a UniEquip vacuum centrifugal equipment, andfurther resuspended in saline plus unlabelled substrates to achieve
the desired concentrations.
2.4. Increase of endogenous enzymatic activities in oocytes
Two strategies were followed: microinjection of commercial en-
zymes for HK, PGM and UGPase, and activation of endogenous GS
by injection of Glc-6-P.
Yeast hexokinase was diluted in Barth saline to achieve the de-
sired concentrations in a volume of 50 nl. For PGM, 150 ll of
ammonium sulfate precipitated enzyme was centrifuged for
10 min at 15,982g. The supernatant liquid was discarded and
the precipitated enzyme was washed in 150 ll of saline. The
enzyme was further concentrated to a ﬁnal volume of 20 ll and ﬁ-
nally diluted in saline. For UGPase, the homogenous enzyme ob-
tained after chromatography on Sephacryl was concentrated and
diluted in saline. In all 3 conditions, increasing amounts of enzyme
were microinjected into the oocytes to obtain at least 4.5 times the
endogenous activity. Unperturbed oocytes (not microinjected) and
oocytes injected with Barth saline were used as controls. After
enzyme microinjection, groups of 10 oocytes were left 1 h in Barth
saline to allow intracellular diffusion of the enzyme. Then, the
oocytes were reinjected with 50 nl of saline containing 6 nmoles
of U-14Cglucose (50,000–100,000 cpm). Groups of 5 oocytes were
incubated during 20 min at 22 in 120 ll saline in sealed tubes
with continuous O2 ﬂow. Labelled CO2 was collected as described
[10].
Since commercial homogenous GS was not available, the endog-
enous activity was increased by microinjecting the oocytes with
different concentrations of Glc-6-P, a potent activator of oocyte
GS [20]. After 8 min, the oocytes were reinjected with 6 nmoles
of [U-14C]glucose. Groups of 5 oocytes were further incubated for
12 min, and CO2 evolution and glycogen were measured. Previous
experiments to ﬁnd the appropriate Glc-6-P concentration produc-
ing the highest enzyme activation during the times required were
performed (Supplementary data).
2.5. Glycogen isolation and CO2 measurement
As described by Ureta et al. [10], groups of 5 oocytes microin-
jected with enzyme and radioactive glucose were incubated in
sealed tubes containing 120 l Barth during 20 min at 22 under
100% O2. CO2 released was collected in connected vials containing
600 l of 0.3 N NaOH and drops of Triton -100. After addition of
4 ml of scintillation mix and 300 l of water, the samples were
counted in a 1600 TR Packard scintillation counter. For glycogen
isolation, individual oocytes were transferred to Eppendorf tubes
containing 200 l of 30% KOH and incubated for 30 min at 100.
Finally, samples were placed on small squares of ET31 Whatman
ﬁlter paper. Air dried papers were left overnight in 66% ethanol
at 20. After, they were washed three times with continuous stir-
ring during 30 min in 66% ethanol at room temperature, dried over
paper towel under infrared light, and placed in vials with 4 ml of
scintillation mixture. Glucose radioactivity incorporated into gly-
cogen was measured in a 1600 TR Packard scintillation counter.
2.6. Protein determination
Protein concentration of the different enzymatic preparations
was determined according to Bradford [21].
2.7. Enzymatic assays
Hexokinase. Enzyme activity was measured by the coupled Glc-
6-P dehydrogenase method [22]. The reaction mixture contained
50 mM Tris–HCl (pH 7.5), 100 mM KCl, 10 mM MgCl2, 5 mM ATP,
Table 1
Endogenous levels of enzymes involved in glycogen synthesis through the direct
pathway in frog oocytes.
Enzyme Activity (mU/oocyte) Relative activity
Hexokinase 0.06 ± 0.004 1
Phosphoglucomutase 9.4 ± 0.93 157
UDPG-pyrophosphorilase 4.3 ± 0.65 72
Glycogen synthase 0.7 ± 0.03 12
Oocyte homogenates were prepared under the conditions described in Section 2 for
each enzyme and centrifuged at 14,000 rpm for 20 min. Enzyme activities were
measured in the obtained supernatant fraction as described in Section 2.
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dehydrogenase in a ﬁnal volume of 1 mL. NADH formation was
monitored at 340 nm in a Unicam UV2-100 spectrophotometer at
28. Oocytes endogenous activity was determined in the superna-
tant fraction obtained after homogenizing 5 oocytes in 100 ll Barth
saline and centrifuging at 15,982g during 25 min. A unit of HK
activity is deﬁned as the amount of enzyme catalyzing the forma-
tion of 1 mol of Glc-6-P per min at 28.
Phosphoglucomutase. Enzyme activity was determined in the
supernatant fraction obtained after homogenizing 1 oocyte/9 ll
of Barth saline and centrifuging 1 h at 15,982g. Activity was mea-
sured by the coupled Glc-6-P dehydrogenase method [23]. Forma-
tion of NADH was monitored at 340 nm in a Hewlett Packard 8453
spectrophotometer at 24. The reaction mixture contained in a ﬁ-
nal volume of 1 ml: 30 mM imidazole buffer (pH 7.5), 3.3 mM
MgCl2, 0.85 mM NAD+, 0.9 mM EDTA, 0.015 mM Glc-1,6-bisP,
1.5 mM glc-1-P and 0.33 U of Glc-6-P dehydrogenase. One unit of
PGM activity is deﬁned as the amount of enzyme catalyzing the
formation of 1 mol of Glc-6-P per min at 24.
UDPG-pyrophosphorylase. The spectrophotometric method
described by Martz et al. [24] was used with slight modiﬁcations.
Oocytes were homogenized 1:2 (oocytes:buffer, w:v) in saline.
The assay medium contained: 1 mM UDP-glucose, 5 mM MgCl2,
0.6 mM NADP+, 3 mM sodium pyrophosphate, 0.02 mM Glc-1,6-
P2, 50 mM bicine (pH 8.5), 0.5 U of PGM, 5.6 U of Glc-6-P-dehydro-
genase and aliquots of the supernatant liquid containing UGPase
activity, in a ﬁnal volume of 1 ml. The production of NADPH was
monitored at 340 nm in a UV 2 UNICAM spectrophotometer. A unit
of UGPase activity is deﬁned as the amount of enzyme required to
reduce 1 lmol of NADP+ per min at 24.
Glycogen synthase. GS activity was measured by following
radioactive glucose incorporation in vivo from UDP[6-3H] glucose
into glycogen, in the absence of Glc-6-P, according to Báez et al.
[20]. Brieﬂy, 50 nl saline containing 3 mM UDP-6-3Hglc (50,000–
100,000 cpm) were microinjected into individual oocytes followed
by incubation in 75 l saline during 10 min at 22. After, 500 l of 30%
KOH were added and the mixture was heated at 100 for 30 min.
The solution was transferred to a glass tube and 100 l of 2% Na2SO4,
40 l of carrier glycogen (5 mg/ml) and 2 ml of 96% ethanol were
added for glycogen precipitation overnight. The mix was centri-
fuged at 3,020g for 2.5 min in a Sorvall RC-5 centrifuge and the
pellet was resuspended in 2 ml of water and reprecipitated during
8 h with 6 ml of 96% ethanol. After centrifugation, the pellet was
resuspended in 1.2 ml of water and the radioactivity present in
1 ml aliquots was measured in a 1600 TR Packard scintillation
counter.
2.8. Puriﬁcation of commercial UGPase
The freeze-dried commercial Sigma enzyme was not homoge-
neous by SDS PAGE, and, more important, it contained contaminat-
ing HK. Further puriﬁcation by chromatography on a Sephacryl
S-200 column (2.1  73 cm) was performed. A sample containing
about 1 mg of commercial enzyme taken directly from the ﬂask,
100 ll of glycerol and 200 ll of buffer (100 mM Tris–HCl pH 7.6,
100 mM KCl) was loaded to the column. HK and UGPase activities
were measured in aliquots of the collected fractions as described.
The fractions containing UGPase activity were pooled, concen-
trated and subjected to rechromatography on the same column.
2.9. Purity of the enzymes to be microinjected
Aliquots of HK, PGM and UGPase were loaded on a 10% poly-
acrylamide gel and submitted to SDS–PAGE to check for purity
(Supplementary data). Also, the activity of the other enzymes
involved in the pathway was checked in each enzyme sample.3. Results
3.1. Endogenous activity of the enzymes involved in glycogen synthesis
Since measurement of the control coefﬁcient of an enzyme
implies changing enzyme activity in order to study the effect of
this perturbation over the ﬂux, previous knowledge of the oocyte
intracellular enzymatic levels is essential. The activities of the four
enzymes involved in the direct pathway for glycogen synthesis in
oocytes are shown in Table 1. The data reveals that HK has the low-
est activity (0.06 mU/oocyte), Comparison of the relative activity of
the enzymes assigning the value of 1 to HK shows that PGM and
UGPase have around 100 fold the HK activity, while GS is 1.5 times
more active. The values obtained were used to estimate the
amount of each enzyme to be microinjected into the cells.
3.2. Purity of the enzyme preparations to be microinjected
All three HK, PGM and UGPase appeared homogenous by
SDS–PAGE (Supplementary Fig. S1). Also, contamination with any
of the other enzymes of the pathway in each enzyme sample was
discarded by direct measurement of the corresponding enzyme
activities (results not shown).
3.3. Remaining intracellular activity of enzymes microinjected into the
oocytes
Control experiments were performed in order to check that the
microinjected enzymes remained active inside the cells. The same
amounts of enzymes used for ﬂux control coefﬁcients estimation
were microinjected into oocytes. After 1 h incubation under the
same conditions used for ﬂux control studies, groups of 10 oocytes
were homogenized and centrifuged, and the corresponding
enzyme activity was measured in the supernatant fraction. As
shown in Table 2 for UGPase, the activity of the microinjected
enzyme remained almost invariant after 1 h inside the cell, with
values between 82% and 107% of the initial activity. This control
was done for each enzyme every time a control coefﬁcient was
to be determined. In the case of GS, where the enzyme was
activated by Glc-6-P microinjection, a slightly different control
was performed. Groups of 10 oocytes treated under the same con-
ditions as the ones used for ﬂux control coefﬁcient calculations
(amounts of Glc-6-P microinjected and incubation times), were
further microinjected with UDP-[6-3H] Glc and GS activity was
measured as described in Section 2.
3.4. Glc-6-P microinjection
Since no commercial GS was available, changes in the intracel-
lular activity of the enzyme was achieved by microinjection if the
allosteric activator Glc-6-P. At 2 mM injected Glc-6-P (6 nmoles
per oocyte) a maximal activation of 2–3 times was obtained. The
effect was transient (probably by the diversion of the compound
Table 2
UGPase activity remaining after 60 min microinjection of enzyme.
Microinjections Microinjected UGPase mU Total, 0 min UGPase mU
Total, 60 min
None 0.0 3.5
Barth saline 0.0 3.4 %
UGPase 1.8 6.1 5.0 82
4.1 7.1 7.5 106
6.2 9.5 9.6 101
8.2 12.2 11.6 95
Groups of 10 oocytes were microinjected for each condition indicated in the table.
At 0 and 60 min incubation, the oocytes were homogenized, centrifuged and
UGPase activity was measured as indicated in Section 2.
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plementary Fig. S2).
3.5. Control coefﬁcient determinations
The results of increasing enzyme activity over the glycogenic
ﬂux in oocytes are shown in Figs. 1A–4A for HK, PGM, UGPase
and GS, respectively. The ﬂux control coefﬁcient with the highest
value (0.61 ± 0.07, n = 4) was obtained for HK. Intermediate coefﬁ-
cients of 0.19 ± 0.03 (n = 4) and 0.13 ± 0.03 (n = 3) were calculatedFig. 1. Flux control coefﬁcient for hexokinase. (A) Oocytes were microinjected with increa
was then reinjected with 6 nmol of [U-14C]Glc and further incubated in groups of 5 for
radioactivity incorporated into the polysacharide was measured. The results correspond t
control coefﬁcient calculation from the data shown in the ﬁgure. (B) In the same experim
was determined as a measure of the operation of the pentose-P pathway. The ﬂux cont
Fig. 2. Flux control coefﬁcient for phosphoglucomutase. Oocytes were microinjected with
The rest of the experiment and calculations were the same as described in Fig. 1.for PGM and UGPase, while the lowest coefﬁcient obtained was for
GS (0.06 ± 0.08, n = 4). As a control of the speciﬁcity of the
observed effects, the inﬂuence of changing these intracellular
enzymatic activities was simultaneously analyzed for the pentose
phosphate pathway. Previous results from our laboratory [25] have
shown that CO2 evolution is solely generated by glucose decarbox-
ylation in this pathway. The control exerted by the glycogenic
enzymes over the ﬂux through the pentose phosphate pathway
was almost null, as shown in Figs. 1B–4B. The ﬂux control coefﬁ-
cients varied from 0.09 for PGM to 0.08 for GS. Another control
included the estimation of the ﬂux control coefﬁcient for HK when
glycogen synthesis proceeded mainly through the indirect path-
way. This route is the prevailing one when glucose administered
to the oocytes is as low as 0.5 nmoles microinjected per cell [17].
A ﬂux control coefﬁcient of 0.05 was estimated for HK in this con-
dition, a result showing that although the enzyme signiﬁcantly en-
hances the ﬂux through glycogen synthesis by the direct pathway
it has no effect over the ﬂux through the indirect route.
4. Discussion
The results reported provide the ﬁrst direct in vivo measure-
ment of the ﬂux control coefﬁcients for the complete set of en-
zymes involved in a metabolic pathway. The values obtained alsosing amounts of HK and groups of 10 cells were preincubated for 1 h at 20. Each cell
20 min in the presence of oxygen. Glycogen was isolated from each oocyte and the
o the mean of 10 oocytes for each group of oocytes ± S.E.M. The inset shows the ﬂux
ent CO2 was collected from groups of 5 oocytes and the radioactivity incorporated
rol coefﬁcient for HK over this pathway was also calculated.
increasing amounts of PGM and groups of 10 cells were preincubated for 1 h at 20.
Fig. 3. Flux control coefﬁcient for UDPG-pyrophosphorylase. Oocytes were microinjected with increasing amounts of UGPase and groups of 10 cells were preincubated for 1 h
at 20. The rest of the experiment and calculations were the same as described in Fig. 1.
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of metabolic control analysis, since the sum of the control coefﬁ-
cients for all the enzymes of the pathway is 0.87 ± 0.05. We may
thereby conclude that it is HK and not GS the enzyme primarily
responsible for the control of the ﬂux in the direct pathway for gly-
cogen synthesis in amphibian oocytes. The ﬁnding that HK was the
enzyme with the highest control coefﬁcient and also with the
lowest endogenous activity agrees with the data reported in the lit-
erature [13]. However, it should be born in mind that since glucose
was microinjected into the cells, the inﬂuence of the glucose trans-
port stage was not taken into account.
The feasibility of frog oocytes to be used as test tubes for in vivo
metabolic studies has been strongly supported by this work. We
were able to increase the intracellular activity of the ﬁrst three
individual enzymes (HK, PGM, UGPase) by directly microinjecting
them into the oocytes and to activate GS by microinjection of
Glc-6P, without affecting the remaining enzyme repertoire of the
cells. Altering enzyme activity by microinjection proved to specif-
ically affect a given pathway. Thus, although hexokinase signiﬁ-
cantly enhances the ﬂux through glycogen synthesis by the
direct pathway it has no effect over the ﬂux through the indirect
route. Also, enzyme microinjection does not affect the ﬂux through
the pentose-P pathway as shown by the respective experiments.
Hence, repeated and reliable results were easily obtained by means
of this experimental approach.
Microinjection of enzymes isolated from the same species
would be the ideal situation for measuring control coefﬁcients. InFig. 4. Flux control coefﬁcient for glycogen synthase. Oocytes were microinjected
concentrations), and groups of 10 cells were preincubated for 8 min. Then, 6 nmol of [U-
rest of the experiment and calculations was as described in Fig. 1.our experiments, the enzymes (excluding GS) were heterologous.
Nonetheless, the yeast hexokinase has extensive sequence and
three dimensional structure similarities with the vertebrate
enzymes [26] and a similar nuclear-cytosolic localization [27].
Similar arguments apply to the other enzymes microinjected. Se-
quence comparison of the yeast Saccharomyces cerevisiae and Xeno-
pus laevis UGPase by the program CLUSTAL W have shown a 50%
amino acid sequence identity [28]. The sequences were obtained
from Genbank with the following access numbers: AAH77213
(Xenopus laevis) and 2124302A (Saccharomyces cerevisiae).
GS activity was increased by microinjection of the allosteric
activator Glc-6-P, which is also an inhibitor (competitive with
ATP) of vertebrate hexokinases. Therefore the lack of control of
GS on glycogen synthesis could perhaps be explained by the de-
crease of the ﬂow through the pathway due to hexokinase inhibi-
tion. Several facts rule out this possibility. It is well known that the
inhibitory effect of Glc-6-P is reversed by Pi [29]. When glycogen
synthesis is operative, UGPase produces large amounts of Pi. High
concentrations of Pi around 3 mM are found in unperturbed oo-
cytes [30]. Moreover, ATP concentration in oocytes is high enough
(3.6 mM) to revert the inhibitory effect of Glc-6P [31]. Finally,
microinjected glucose-6-P is also drained both by the indirect
pathway for glycogen synthesis and the pentose-P pathway. Thus,
hexokinase should not be inhibited by microinjected Glc-6-P.
Another possibility to be considered is that GS, being a highly
regulated enzyme, could be inactive or not available for glycogen
formation in our experiments. We have previously shown thatwith increasing amounts of Glc-6P (0.13, 0.25, 0.5 and 0.75 mM, intracellular
14C]Glc were injected into each oocyte and the cells were incubated for 12 min. The
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ciently incorporated into glycogen [15]. Besides, the results in this
paper demonstrate that glycogen synthesis proceeds at least for
1 h in oocytes microinjected with HK and 20 min after glucose
administration. Finally, the lack of control observed for GS could
be inﬂuenced by phosphorylase since it has been reported that
the enzyme has a high negative control coefﬁcient (greater than
1.0) in hepatic glycogen synthesis [32]. However, unpublished
results from our laboratory indicate that after 2 h of radioactive
glucose microinjection, 90% of the label is recovered as glycogen,
suggesting that the polysaccharide is very stable in frog oocytes,
Also, phosphorylase should be dephosphorylated and hence inac-
tive at high glucose concentration, which is the case in our
experiments.
The lack of ﬂux control exerted by glycogen synthase is fully
consistent with the regulation of glycogen synthesis in mammals
by the blood-glucose level, i.e. it is a pathway regulated by supply
[33]. Although comparable information is lacking in other verte-
brates it is realistic to think that similar principles should apply.
Glycogen synthesis in oocytes will thus differ from the much more
usual case of regulation by demand for end product, in which the
principal effect of feedback inhibition is to provide information
to the regulated enzymes early in the pathway about the demand
for the end product [34]. This type of behavior is clearly seen in a
recent study of feedback inhibition of aspartate metabolism in Ara-
bidopsis thaliana [35,36].
A top-down approach to MCA which deﬁnes control over a few
metabolic components of a pathway, each consisting of a number
of enzymes, has been applied to glycogen synthesis in insulin stim-
ulated rat skeletal muscle [37]. The authors studied the control of
the ﬂux for glucose disposal among glucose transport/phosphory-
lation [GLUT-4/hexokinase (HK)], glycogen synthesis, and glycoly-
sis. A ﬂux control coefﬁcient of 0.55 ± 0.1 for the glut 4/HK
component, and of 0.3 ± 0.06 for the glycogen synthesis component
(PGM, UGPase and GS) was found, while the contribution of glycol-
ysis was equal to 0.15 ± 0.02. These results are similar to the ones
reported by us in this paper (0.61 for HK and 0.26 for the sum of
PGM, UGPase and GS).
In agreement with these results is the proposal of Schafer and
co-workers in muscle cells [38], stating that the control of the ﬂux
would be at the beginning of the pathway at the glucose
transporter-HK level and that GS would allow, by means of its
regulatory properties, the maintenance of constant metabolite
concentrations. Thus, the glycogen synthesis pathway would
accomplish the dual requirement of changing the ﬂux while main-
taining metabolite homeostasis.
The results presented in this work and others suggest that the
role of hexokinase in controlling the ﬂux in glycogen synthesis is
not restricted to mammalian species (this work) nor to glycogen
metabolism. It has been shown that changes in the activity of glu-
cokinase in mouse are responsible for high metabolic control on
glycolysis [39] and that hexokinase has an important control in
the glycolytic ﬂux in Drosophila [40].
As far as we know, ﬂux control coefﬁcients for PGM and UGPase
are only available in plants. The control exerted by these enzymes
on starch synthesis from sucrose in potato tubers was reviewed by
Geigenberger et al. [41]. For cytosolic and plastidial PGM, ﬂux con-
trol coefﬁcients reported were 0.15 and 0.23, respectively. In the
case of UGPase, the value reported was near 0.0. Although these
ﬁndings cannot be directly extrapolated from plants to amphibia,
the ﬂux control coefﬁcients for PGM are similar to the one deter-
mined in our study, reinforcing the idea that PGM has a low control
in polysaccharide synthesis.
Finally, we would like to state that, beyond the results obtained
in this paper, we are aware that glycogen synthesis constitutes a
subset of the networks and networks interactions that occur in awhole cell or system (for a review see [42]. The contribution of dif-
ferent components of the network to regulation will vary, depend-
ing on the perturbation of the system. An in-depth understanding
of the regulation of a metabolic process therefore requires an anal-
ysis of how it responds to all of the major perturbations to which it
is typically exposed [41]. Nevertheless, network-based pathway
analysis is beyond the scope of this work.
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